.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Erdheim-Chester disease (ECD) is a multisystemic histiocytic neoplasm often identified by skeletal and visceral involvement. However, recent medical literature emphasizes the importance of recognizing atypical Erdheim-Chester disease skin lesions. Specifically, some patients develop glomeruloid haemangiomas and extensive angiomas. These lesions occur even when the classic features of POEMS syndrome are absent. Investigators have linked these findings to markedly elevated levels of vascular endothelial growth factor-A (VEGF-A).
Research demonstrates that MAPK-activated histiocytes drive these skin changes through a paracrine mechanism. Molecular analyses show that the histiocytes themselves harbor the activating mutations rather than the endothelial cells. Consequently, these histiocytes secrete VEGF-A, which stimulates localized blood vessel growth. This unique pathway explains why vascular proliferations appear in these patients. Furthermore, this mechanism differentiates these lesions from those caused by intrinsic vascular mutations.
Notably, the presence of glomeruloid haemangiomas often suggests POEMS syndrome. However, in the context of ECD, these lesions emerge due to systemic cytokine elevations. Clinicians should therefore screen patients with atypical vascular lesions for underlying histiocytic disorders. Treatment often targets the underlying MAPK pathway using BRAF or MEK inhibitors. Monitoring VEGF-A levels may also provide insight into disease activity and treatment response.
The most common skin findings are periorbital xanthelasma-like lesions. However, atypical vascular lesions like glomeruloid haemangiomas can occur due to high VEGF-A levels.
Histiocytes with MAPK mutations produce VEGF-A. This factor acts on nearby blood vessels to cause abnormal proliferation, leading to angiomas in the skin.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Recent studies reveal that Erdheim-Chester disease can manifest as glomeruloid haemangiomas driven by elevated VEGF-A levels. This discovery highlights a paracrine mechanism involving MAPK-activated histiocytes, providing new insights into the atypical cutaneous manifestations of this rare histiocytic neoplasm.
4 months ago
Depemokimab offers twice-yearly dosing for severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps, significantly cutting exacerbations and hospital admissions.
4 days back
A novel copper metal-organic framework hydrogel remodels the uterine microenvironment to stimulate robust endometrial regeneration, reduce intrauterine fibrosis, and restore reproductive fertility, offering a groundbreaking strategy for managing refractory endometrial damage and Asherman syndrome.
4 days back
New research reveals that non-ablative radiotherapy suppresses ventricular tachycardia by increasing conduction velocity via NaV1.5 upregulation and action potential prolongation. However, sustained sodium current elevation and depressed calcium handling highlight the need for careful clinical translation.
6 days back
A single-cell transcriptomic atlas reveals how peripheral nerve injuries cause dorsal root ganglion remodeling. By evaluating proximal nerve crush and resection, researchers identify distinct glial and immune programs that resolve neuropathic pain and promote regeneration.
4 days back
A breakthrough study demonstrates that fullerol-primed extracellular vesicles generated in a 3D SECCS bioreactor attenuate ferroptosis and restore myogenic regeneration in diabetes via the FOXO3 pathway, offering a cell-free therapeutic strategy for diabetic musculoskeletal degeneration.
4 days back
